Adicet Bio, Inc. (ACET)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Adicet Bio, Inc. (ACET)
Company Performance

Current Price

as of Oct 16, 2024

$1.49

P/E Ratio

N/A

Market Cap

$122.78M

Description

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Metrics

Overview

  • HQBoston, MA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerACET
  • Price$1.49+6.43%

Trading Information

  • Market Cap$122.78M
  • Float80.36%
  • Average Daily Volume (1m)502,986
  • Average Daily Volume (3m)560,709
  • EPS-$2.53

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$29.90M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$31.25M
  • EV-$95.27M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B0.52
Documents